Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1967 8
1968 3
1969 2
1970 4
1971 3
1972 1
1973 3
1974 1
1977 1
1978 1
1979 2
1980 2
1982 3
1983 1
1984 1
1985 1
1986 2
1987 2
1988 2
1989 2
1990 8
1992 6
1993 3
1994 5
1995 7
1996 4
1997 9
1998 5
1999 9
2000 9
2001 13
2002 9
2003 5
2004 5
2005 17
2006 17
2007 14
2008 12
2009 8
2010 6
2011 12
2012 3
2013 3
2014 1
2015 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

225 results
Results by year
Filters applied: . Clear all
Page 1
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.
von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF. von der Maase H, et al. Among authors: dogliotti l. J Clin Oncol. 2000 Sep;18(17):3068-77. doi: 10.1200/JCO.2000.18.17.3068. J Clin Oncol. 2000. PMID: 11001674 Clinical Trial.
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A, Arning M. von der Maase H, et al. Among authors: dogliotti l. J Clin Oncol. 2005 Jul 20;23(21):4602-8. doi: 10.1200/JCO.2005.07.757. J Clin Oncol. 2005. PMID: 16034041 Clinical Trial.
[Chronochemotherapy].
Dogliotti L, Garufi C, Iacobelli S. Dogliotti L, et al. Tumori. 2000 May-Jun;86(3 Suppl):S32-6. Tumori. 2000. PMID: 10969615 Review. Italian. No abstract available.
Emerging drugs for adrenocortical carcinoma.
Berruti A, Ferrero A, Sperone P, Daffara F, Reimondo G, Papotti M, Dogliotti L, Angeli A, Terzolo M. Berruti A, et al. Among authors: dogliotti l. Expert Opin Emerg Drugs. 2008 Sep;13(3):497-509. doi: 10.1517/14728214.13.3.497. Expert Opin Emerg Drugs. 2008. PMID: 18764725 Review.
Gene expression profiling in breast cancer: a clinical perspective.
Arpino G, Generali D, Sapino A, Del Matro L, Frassoldati A, de Laurentis M, Pronzato P, Mustacchi G, Cazzaniga M, De Placido S, Conte P, Cappelletti M, Zanoni V, Antonelli A, Martinotti M, Puglisi F, Berruti A, Bottini A, Dogliotti L. Arpino G, et al. Among authors: dogliotti l. Breast. 2013 Apr;22(2):109-120. doi: 10.1016/j.breast.2013.01.016. Epub 2013 Feb 23. Breast. 2013. PMID: 23462680 Free article. Review.
The endocrine basis of benign breast disorders.
Dogliotti L, Orlandi F, Angeli A. Dogliotti L, et al. World J Surg. 1989 Nov-Dec;13(6):674-9. doi: 10.1007/BF01658413. World J Surg. 1989. PMID: 2696218 Review.
Laboratory tests for neuroendocrine tumours.
Seregni E, Ferrari L, Stivanello M, Dogliotti L. Seregni E, et al. Among authors: dogliotti l. Q J Nucl Med. 2000 Mar;44(1):22-41. Q J Nucl Med. 2000. PMID: 10932599 Review.
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach.
Fitzpatrick JM, Anderson J, Sternberg CN, Fleshner N, Fizazi K, Rébillard X, Dogliotti L, Conti G, Turesson I, James N, Heidenreich A, Solsona E, Guillem V, Herchenhorn D, Moul J, van Moorselaar J, Coetzee LJ, Wilson A, Bamias A, De Wit R, Chrisofos M. Fitzpatrick JM, et al. Among authors: dogliotti l. Crit Rev Oncol Hematol. 2008 Oct;68 Suppl 1:S9-S22. doi: 10.1016/j.critrevonc.2008.07.019. Epub 2008 Aug 23. Crit Rev Oncol Hematol. 2008. PMID: 18723368 Review.
225 results